Arovella chases world-first cancer therapy
Arovella Therapeutics has an important ally in its campaign to develop a unique cell therapy targeting gastric and other cancers. Get your health news here.
Arovella Therapeutics has an important ally in its campaign to develop a unique cell therapy targeting gastric and other cancers. Get your health news here.
Virgin Australia’s planned $3 billion IPO is big, but another rumoured listing could be even more stunning. Here are the stocks ready to roll.
Why one fund sees potential returns on Aussie stocks as far more fun than term-bank deposits, fickle bonds and overseas shares despite the September-season profit slump.
Online marketplaces are set for a pre-Christmas boom, with new research showing 80 per cent of Aussies will use them. That would be make these stocks so jolly.
Goldman Sachs says Australia’s big miners are outperforming international peers and remain undervalued. And it quite likes gold stocks, too.
ASX-listed companies are adding to the energy mixes of Africa’s burgeoning resources scene amid booming electricity needs for the fastest-growing population.
Bill Beament’s Develop adds 40pc to the beefy copper and zinc at its Woodlawn base metals mine in NSW. Plus Essential Metals and Boss Energy.
When the world zigs, Mark Creasy ZAGs. He’s pumped funding into Zuleika, among gainers in the yellow metal corner.
Bitcoin just can’t seem to get over that $US28,000 wall. And yet, Bloomberg’s crypto strategist is seeing an ‘interesting’ bullish signal.
ASX stock Pure Resources has a potentially lucrative stake in the frenzied North American lithium chase – and the market has shared its enthusiasm.
Paradigm Biopharma’s knee osteoarthritis drug has shone in trials, easing pain and improving joint function. Now the firm is seeking TGA approval.
As it expands its range of premium products, Rare Foods Australia has signed a deal with a leading French wine company to trial patented bulk production methods.
Australia may head further down the green iron value chain with plans for a huge WA processing plant now before the Environmental Protection Authority.
Euroz Hartleys reckons it may be worth taking the plunge into this Matrix, while Taylor Collison is eyeing an engineering outfit. Welcome to MoneyTalks.
Bitcoin, Ethereum and most other notable cryptos appear to be in a ‘chop-solidation’ period for the moment. But some observers are predicting a breakout soon.
Maiden test work at Azure Minerals’ giant Andover hard rock lithium project is off to a great start, with impressive grades and recovery percentages.
The fight against ovarian cancer has taken a step forward, with Cleo Diagnostics confirming early milestones in the development program for its test-kit.
Record sales have delivered Melodiol Global Health’s wholly-owned Canadian subsidiary Mernova its third consecutive quarter of revenue growth.
Copper stocks been pounded – creating value for canny investors, says veteran mining columnist Barry FitzGerald. He’s eyeing two small caps with huge potential.
Wellnex Life wants to secure at least $12 million in fresh capital to facilitate a more favourable acquisition of Pain Away, alongside preparations for a London Stock Exchange debut.
Pediatric patients with orphan disorder PANDAS/PANS could have a new treatment available after a groundbreaking Neurotech trial indicated significant improvements.
Nickel’s fundamentals are ‘more secure’ than lithium’s and a rise is coming, says VP Capital’s John So. That will cheer these miners, who have access to both.
Red Leaf Securities boss Jonathon Howe expects the tech sector to be an early riser when interest rates settle down. Meanwhile, he says these stocks offer value.
As the hunt for mineral deposits becomes more difficult, old-fashioned ways of exploring are falling by the wayside, as this sort of tech takes over.
It seems that the wages of ‘sin’ (stocks) are not as high as they once were. And you can bet that will cause some tension among the ranks, says Tim Boreham.
Three ASX stocks – including one soon to list – were victors in a fight to stake claims in South Dakota’s Black Hills. Now the area is enjoying a lithium rush.
You don’t have to go big to enter the bullish uranium scene. Reach into Stockhead’s bargain barrel for promising stocks with sub-$40m market caps.
Thought the US Fed interest rate decision was going to stir Bitcoin into action? Nope, it’s just taking it easy. But another coin is running hard.
NSW-exploring Australian Gold and Copper has had a stock price bump after landing more than $10 million of investment from a Hong Kong-based group.
In the wake of huge US IPOs that had investors in a frenzy, experts have cautioned against being swept up in hype. And the ASX is no different.
Catalysts such as the outcomes of clinical trials can rocket biotech stocks to new heights. And these ASX firms are on the cusp of potentially game-changers.
Uranium has had many false dawns. But the Sprott trust, industry leaders and a decade-high spot price suggest its time in the sun has arrived.
Bitcoin is showing a bit of bottle to stay above $US27k ahead of the US Federal Reserve’s interest rates decision. And a famous indicator looks cheery.
Rio Tinto CEO Jakob Stausholm expects huge growth in lithium demand by the end of the decade, but has ruled out an M&A offensive.
‘Drone in the box’ technology is unpacking big opportunities, says ASX stock RocketDNA. Here’s what it is, what it does and why it’s a game-changer.
Azure continues to highlight the significance of its already stunning Andover lithium discovery in WA, with drilling returning more high-grade lithium intersections.
Cancer is global health enemy No.1. And a new generation of ASX stocks is continuing Australia’s proud history of taking on the killer.
Woolworths or Coles? Goldman Sachs analysts have made their call as they compare some key choices facing investors in the retail sector.
The film industry couldn’t have scripted this plot twist any better. Movie buffs are streaming back, delighting Hollywood and co-stars such as Vista Group.
Drilling has yielded an impressive new discovery at Marwari – revealing a trend longer than 350m at Strickland’s Yandal gold project in WA.
For so long lithium plays have been the darling of investors. But now some are getting love of another kind – from short sellers.
Magnis Energy Technologies says graphite looms as the great constant as battery tech evolves – and a supply deficit is tipped within two years.
Nero Resources Fund founder Russell Delroy is a fan of two much-maligned sectors. And he loves gold and this ‘undervalued’ lithium stock too.
Bitcoin is holding steady as we head into a week overshadowed by a looming critical US Federal Reserve interest rates decision.
Perseus Mining says its Yaoure operation in West Africa will be delivering gold until 2035 – and that it is set to head underground for the first time.
Popular multi-chain non-custodial crypto wallet BitKeep’s transformative brand upgrade to become Bitget Wallet is much more than just cosmetic.
The Secret Broker says even the best of us can be milked by dodgy characters. Sometimes you can even get ‘goated’. Let him explain …
Canadian explorers are swarming to the ASX. And the boss of an impending arrival has revealed why Australia is hitting the sweet spot.
Bailador’s regular fully franked dividends provide ongoing yields superior to cash and investors also get exposure to capital gains associated with investing in high-grow tech.
Maybe the iPhone #15 will prove to be dynamite or maybe not, but Apple’s annual product launch was more about Apple’s own future | WATCH.
Original URL: https://www.heraldsun.com.au/business/stockhead/page/54